I thought of Baxter and Shire because they are both companies that have publicly stated acquisitions are part of their strategy (and have done numerous deals) and they are both involved in Biologics... and in my little world of companies I am somewhat familiar with :- )
I didn’t think much of your rationale when you posted it, but you got the right answer and it’s hard to argue with that! I hope MNTA’s involvement in this endeavor will enable BAX to outdo its reputation. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”